Athos Capital LTD Pacific Biosciences Of California, Inc. Transaction History

Athos Capital LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$2.36 - $5.26 $163,831 - $365,149	-69,420 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$4.6 - $5.57 $319,332 - $386,669	69,420 New	69,420 $357,000
Q3 2019 Nov 13, 2019	SELL	$4.99 - $6.16 $246,406 - $304,180	-49,380 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$5.92 - $7.41 $924,958 - $1.16 Million	-156,243 Reduced 75.99%	49,380 $299,000
Q1 2019 May 14, 2019	BUY	$6.8 - $7.4 $908,928 - $989,128	133,666 Added 185.76%	205,623 $1.5 Million
Q4 2018 Feb 08, 2019	BUY	$3.99 - $7.82 $287,108 - $562,703	71,957 New	71,957 $532,000

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Athos Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Athos Capital LTD with notifications on news.